|
Volumn 18, Issue 1, 2001, Pages 35-40
|
Short- and long-term behavioural and medical effects of the OTC introduction of the first H2-blocker in Sweden
a a a a a |
Author keywords
Dyspepsia; H2 blockers; Over the counter; Pharmaceutical intervention; Primary health care; Self medication
|
Indexed keywords
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
NON PRESCRIPTION DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DYSPEPSIA;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LIFESTYLE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT ATTITUDE;
PHARMACEUTICAL CARE;
PRESCRIPTION;
RISK BENEFIT ANALYSIS;
SWEDEN;
|
EID: 0035092165
PISSN: 02810662
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (25)
|